Get ready for an exciting online fireside chat with Vivos Therapeutics, a leading medical device and healthcare services company, on December 16, 2025, at 11 am EST! This is a must-attend event for anyone interested in the future of sleep-related breathing disorder treatments.
The Power of Innovation in Sleep Health
Vivos Therapeutics is at the forefront of revolutionizing how we approach sleep apnea and other breathing disorders. With their innovative diagnostic procedures and proprietary treatments, they are changing the game. But here's where it gets controversial: while the medical community has made progress, there's still a lot we don't fully understand about breathing and sleep health.
A Strategic Pivot and Growth Strategy
Vivos' CEO Kirk Huntsman and CFO Brad Amman will be joining Robert Sassoon, a senior research analyst from Water Tower Research, to discuss their strategic business model pivot and the execution of their operational plans. They will delve into the market opportunity and competitive landscape, as well as Vivos' growth and financial strategies. This is a unique chance to gain insights into how Vivos plans to navigate the complex world of sleep apnea treatments and make a significant impact.
Register Now and Don't Miss Out!
To join this exclusive listen-only event, simply register at the link provided. The fireside chat will be available for replay for 30 days in the "Investor Relations" section on Vivos' website, so you won't miss a thing.
About Vivos Therapeutics
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is dedicated to improving the lives of those suffering from breathing and sleep issues caused by dentofacial abnormalities. Their FDA-cleared devices are designed to treat all severity levels of obstructive sleep apnea (OSA) in adults and moderate-to-severe OSA in children. With their groundbreaking Complete Airway Repositioning and Expansion (CARE) devices, Vivos is leading the way in innovative treatments for severe OSA in adults and children.
OSA is a global issue, affecting over 1 billion people, yet most remain undiagnosed. It's not just a sleep problem; it's a chronic health condition with serious implications. Vivos is committed to changing this reality through education, technology, and strategic collaborations with sleep healthcare providers.
The Vivos Method: A Hopeful Solution
Vivos calls their unique, nonsurgical, noninvasive, and nonpharmaceutical approach to treating OSA "The Vivos Method." This proprietary solution offers clinical effectiveness and provides a ray of hope for patients to breathe new life.
Forward-Looking Statements and Potential Risks
While Vivos is optimistic about its future, it's important to note that there are risks and uncertainties involved. These include the potential challenges of integrating acquired businesses, the effectiveness of their products for all patients, regulatory scrutiny, financing availability, and market conditions. Vivos' SEC filings provide more detailed information on these risks.
Join the Conversation
This fireside chat is an opportunity to learn more about Vivos' innovative approach and its potential impact on the sleep apnea treatment landscape. And this is the part most people miss: it's also a chance to engage in a thought-provoking discussion. So, register, listen, and don't forget to share your thoughts and questions in the comments. Let's spark a conversation about the future of sleep health!
